Stay updated with breaking news from Peeter Padrik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New funds will allow the Estonian company to enter new markets in Europe and to invest in its pipeline of polygenic risk score-based tests.
The funding will allow the company to scale its team and introduce its polygenic risk score tests for cancer prevention to new markets.
The Estonian health technology company Antegenes has raised €2.3 million in funding to bring its genetic tests for personalised cancer prevention into wider use in health care, scale the team and expand to new foreign markets.
The funding will allow the company to scale its team and introduce its polygenic risk score tests for cancer prevention to new markets.
Tartu-based startup Antegenes has raised 2.3 million euros in funding from Enterprise Estonia and the European Institute of Innovation and Technology.